Medcaw Investments is seeking suitable acquisitions in the life sciences sector, particularly those companies involved in medical technologies or therapies. Because of the change in rules for the standard list that target must make the enlarged company worth at least £30m when it applies for readmission. Medcaw Investments was able to float, because it had […]

The post New standard listing: Medcaw Investments seeks wellness acquisition appeared first on UK Investor Magazine.

Uniphar shares gained 1.7% to 302.5p in late morning trading on Tuesday, after the company reported a 2.8% revenue increase to €991 million in HY1 2022 against €964 million the year before. The firm announced an 8.8% gross profit climb to €146 million compared to €134 million, alongside a gross profit margin rise to 14.7% […]

The post Uniphar gross profits climb to €146m on strong performance across all divisions appeared first on UK Investor Magazine.

Uniphar shares declined 2.3% to 310p in late afternoon trading on Tuesday after the group confirmed an EBITDA and gross profit performance in line with management expectations in its HY1 trading update. The healthcare services company reported a gross profit rise of 5%, driven by organic growth across each sector and outperformance in its Supply […]

The post Uniphar confirms strong outlook on steady M&A pipeline appeared first on UK Investor Magazine.

Intelligent Ultrasound Group shares fell 2% to 14.2p in late afternoon trading on Thursday following a reported 60% anticipated revenue climb to £5.6 million in HY1 2022 compared to £3.6 million in HY1 2021 as a result of strong performance in UK stimulation sales. The firm commented its stimulation related revenues from its direct sales […]

The post Intelligent Ultrasound Group revenues climb 60% on strong UK stimulation sales appeared first on UK Investor Magazine.

Tissue Regenix Group shares were up 2.4% to 0.5p in late afternoon trading on Tuesday following confirmation of strong trading in line with management expectations in HY1 2022, with a revenue climb of 25% to $11.8 million against HY1 2021. The company announced its board was confident of meeting its FY 2022 expectations. Tissue Regenix […]

The post Tissue Regenix Group confirms trading in line with expectations, revenue climbs 25% in HY1 2022 appeared first on UK Investor Magazine.

Totally shares fell 3.5% to 43.9p in late afternoon trading on Tuesday following a reported 12% growth in revenue to £127.4 million in FY 2022 compared to £113.7 million in FY 2021. The company announced a 24% climb in underlying EBITDA to £6.2 million against £5 million, alongside a rise in pre-tax profit to £1.3 […]

The post Totally revenues increase to £127.4m on higher demand appeared first on UK Investor Magazine.

Worldwide Healthcare Trust shares were down 0.3% to 3,074.7p in early morning trading on Friday, after the group announced a net asset value (NAV) per share total return loss of 5.8% in FY 2022 compared to a 30% return in FY 2021. The trust fell 26.2% against the MSCI World Health Care Index benchmark total […]

The post Worldwide Healthcare Trust NAV return tumbles 35.8% appeared first on UK Investor Magazine.

Trading platform, IG Prime, published a white paper laying out the views of 253 hedge fund managers, on which sectors are most likely to grow over the next twelve months. Within the 41-page document, titled ‘Hedge fund trends: Covid-19 vs the global financial crisis’, 73% of those surveyed said that health and pharma will increase […]

The post Hedge fund managers are divided over an airline recovery in 2021 appeared first on UK Investor Magazine.

Provider of software solutions for the US healthcare sector, Craneware (AIM:CRW) saw its shares bounce on Tuesday, as it announced a “return to strong sales growth” ahead of its AGM. The company said that trading during the first four months of the fiscal year were ahead of management expectations, and “considerably ahead” of the same […]

The post Craneware shares soar with ‘return to strong sales growth’ appeared first on UK Investor Magazine.

Trying to manage money during a global pandemic is challenge enough, but trying to position yourself as an investor in an uncertain climate is an even greater cause for sleepless nights. The predominant issue here is uncertainty. Not necessarily over what the virus will do next, but the week-by-week adjustments in political policy that are […]

The post Fortune 500 data scientist backs tech rally but gold and bitcoin could see volatility appeared first on UK Investor Magazine.

Between Donald Trump’s handling of the COVID pandemic, protests and ongoing investigations into his potential involvements in several scandals, the US president has certainly seen his stock fall in the last couple of months. While most of his cards will rest upon his ability to inspire a quick economic bounce-back from the virus, most polling […]

The post Biden favourite to win presidency: how investors should ride the ‘blue wave’ appeared first on UK Investor Magazine.

Cambridge Cognition Holdings plc (AIM:COG), a leading digital neuroscience software development firm, has teamed up with charity 4YouandMe and The Centre for International Emergency Medical Services (CIEMS) to launch a study using mobile phones to assess the stress recovery rates of frontline Covid-19 healthcare workers in the USA. The project is to be funded by […]

The post New virtual study to measure stress in Covid-19 healthcare workers appeared first on UK Investor Magazine.

Value Cycle software solutions for the US healthcare market Craneware (LON:CRW) saw its earnings jump during the first half of 2020, led by a 30% year-on-year rise in ‘new sales’. Despite the fact that its revenues were almost flat at $35.9 million, its adjusted EBITDA bounced 10% on-year, to $12.7 million, and its PBT rose […]

The post Craneware books strong first half led by 30% growth in ‘new sales’ appeared first on UK Investor Magazine.

Genetic test developer Genedrive (LON:GDR) saw its shares go into free fall as its losses widen year-on-year. During the six months ended December 31 2019, the company’s losses stood at £2.57 million, widening from £1.38 million for the same period a year earlier. Further, its loss per share grew from 7.0p to 8.9p The company […]

The post Genedrive shares dive 64% as losses double appeared first on UK Investor Magazine.

French multinational pharmaceuticals company Sanofi SA (EPA: SAN) booked strong sales performance during the third quarter of FY19, but was marred by drop offs in some of its fundamentals. Elsewhere, Deltex Medical Group plc (LON: DEMG) also posted a drop in revenues, while Curetis NC (AMS: CURE) and Integumen PLC (LON: SKIN) both boasted revenue […]

The post Sanofi boasts sales growth but cannot salve its IFRS fundamentals appeared first on UK Investor Magazine.

Healthcare-focused real estate investment trust Impact Healthcare REIT PLC (LON: IHR) announced on Monday morning that it had acquired a property asset outside of Bristol. The exchange of contracts for the Argentum Lodge Care Home facility was undertaken for a consideration of £6.95 million, with initial rental income of £0.467 million. Speaking on the acquisition, […]

The post Impact Healthcare REIT continues investment with care home acquisition appeared first on UK Investor Magazine.

Developer of molecular diagnostic solutions, Curetis NC (AMS: CURE) has seen its losses narrow year-on-year for the first half, as the Company makes good progress in revenue growth. The Group’s revenues grew by 35% during the first half of the financial year, up from EUR 0.8 million to EUR 1.09 million. Alongside this, the Group’s […]

The post Curetis finds a salve for its losses as revenues hike 35% appeared first on UK Investor Magazine.

Biotechnology company OptiBiotix Health PLC (LON: OPTI) has seen its share price dive despite gaining new licences and partnerships during the first half of the year. Regarding licences and approvals; the Group gained a CE mark for its SlimBiome product, its cholesterol and blood pressure reducing Lactobacillus plantarum LP-LDL probiotic strain was determined as Generally […]

The post OptiBiotix Health shares in free-fall despite operational progress appeared first on UK Investor Magazine.

Commercial healthcare technology group NetScientific PLC (LON:NSCI) have posted a full-year loss, which the company said reflected ongoing investment activity in its portfolio companies, which was part of its business strategy. NetScientific update summary and comments The firm posted a pre-tax loss for the full year throigh December, of £4.1 million, which narrowed from £4.4 […]

The post NetScientific investments lead to annual loss appeared first on UK Investor Magazine.

Aspiring leading ‘out-of-hospital’ healthcare service provider, Totally plc (LON:TLY) announced that their subsidiary, Vocare had won a contract worth £13.5 million, awarded by the NHS Newcastle & Gateshead Clinical Commissioning Group. Outsourcing trend The firm stated that the contract detailed provision of Urgent Treatment Centre and GP Visiting Services for the next five years, with […]

The post Totally awarded £13.5m NHS contract appeared first on UK Investor Magazine.